Abstract:Proteins are the molecular machinery of the human body, and their malfunctioning is often responsible for diseases, making them crucial targets for drug discovery. The three-dimensional structure of a protein determines its biological function, its conformational state determines substrates, cofactors, and protein binding. Rational drug discovery employs engineered small molecules to selectively interact with proteins to modulate their function. To selectively target a protein and to design small molecules, knowing the protein structure with all its specific conformation is critical. Unfortunately, for a large number of proteins relevant for drug discovery, the three-dimensional structure has not yet been experimentally solved. Therefore, accurately predicting their structure based on their amino acid sequence is one of the grant challenges in biology. Recently, AlphaFold2, a machine learning application based on a deep neural network, was able to predict unknown structures of proteins with an unprecedented accuracy. Despite the impressive progress made by AlphaFold2, nature still challenges the field of structure prediction. In this Perspective, we explore how AlphaFold2 and related methods help make drug design more efficient. Furthermore, we discuss the roles of predicting domain-domain orientations, all relevant conformational states, the influence of posttranslational modifications, and conformational changes due to protein binding partners. We highlight where further improvements are needed for advanced machine learning methods to be successfully and frequently used in the pharmaceutical industry.

Artificial intelligence for microbial biotechnology: beyond the hype

The prospects and opportunities of protein structure prediction with AI

[Bioinformatics] Artificial Intelligence Learns Protein Prediction

Recent Advances and Challenges in Protein Structure Prediction

The Nobel Prize in Chemistry: past, present, and future of AI in biology

Advancing microbial production through artificial intelligence-aided biology

AI: A transformative opportunity in cell biology

Review of AlphaFold 3: Transformative Advances in Drug Design and Therapeutics

Artificial Intelligence for Microbiology and Microbiome Research

Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence

Improving the odds: Artificial intelligence and the great plate count anomaly

AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges

Advances in AI for Protein Structure Prediction: Implications for Cancer Drug Discovery and Development

Artificial intelligence-aided protein engineering: from topological data analysis to deep protein language models

Overview of AlphaFold2 and breakthroughs in overcoming its limitations

An outlook on structural biology after AlphaFold: tools, limits and perspectives

Artificial Intelligence is Empowering Chemistry Research

AI told you so: navigating protein structure prediction in the era of machine learning

The power and pitfalls of AlphaFold2 for structure prediction beyond rigid globular proteins

AlphaFold, Artificial Intelligence (AI), and Allostery

Can AI design life?